Ampio Pharmaceuticals Inc (NYSE American:AMPE)

3.15
Delayed Data
As of Apr 20
 +0.06 / +1.94%
Today’s Change
0.38
Today|||52-Week Range
4.95
-22.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization303.5K303.7K303.6K303.7K
 
 
 
 
 
 
Operating ExpensesGross Income-303.5K-303.7K-303.6K-303.7K
 
 
 
 
 
General Expenses2.7M4.4M2.8M4.5M
 
 
 
 
 
Research And Development1.6M3.3M2.0M3.4M
 
 
 
 
 
Total Operating Expenses3.0M4.7M3.1M4.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.0M-4.7M-3.1M-4.8M
 
 
 
 
 
Extraordinary Credit1.1M2.1M0.00--
 
 
 
Extraordinary Charge0.000.00-1.2M-38.3M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.9M-2.6M-4.3M-43.1M
 
 
 
 
 
Net Income-1.9M-2.6M-4.3M-43.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS57.2M60.6M68.2M74.9M
 
 
 
 
 
Shares To Calculate EPS Diluted57.2M60.6M68.2M74.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03-$0.04-$0.06-$0.58
 
 
 
 
 
EPS Diluted-$0.03-$0.04-$0.06-$0.58